Forte Biosciences Inc (NASDAQ: FBRX): Stock Forecast For 2024 Sees A An Incline Of 22.72%

EVTL

In today’s recent session, 12.05 million shares of the Forte Biosciences Inc (NASDAQ:FBRX) have been traded, and its beta is 0.07. Most recently the company’s share price was $14.96, and it changed around $9.03 or 152.48% from the last close, which brings the market valuation of the company to $21.87M. FBRX at last check was trading at a discount to its 52-week high of $21.25, offering almost -42.05% off that amount. The share price’s 52-week low was $4.11, which indicates that the recent value has risen by an impressive 72.53% since then. We note from Forte Biosciences Inc’s average daily trading volume that its 10-day average is 12560.0 shares, with the 3-month average coming to 11.91K.

Forte Biosciences Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended FBRX as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Forte Biosciences Inc is expected to report earnings per share of -2.74 for the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Forte Biosciences Inc (NASDAQ:FBRX) trade information

Instantly FBRX has been showing a green trend so far today with a performance of 152.48% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 15.98 on recent trading dayincreased the stock’s daily price by 6.38%. The company’s shares are currently down -27.18% year-to-date, but still up 163.84% over the last five days. On the other hand, Forte Biosciences Inc (NASDAQ:FBRX) is 214.95% up in the 30-day period. We can see from the shorts that 982.0 shares have been sold at a short interest cover period of 0.09 day(s).

Forte Biosciences Inc (FBRX) estimates and forecasts

Forte Biosciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -0.27 percent over the past six months and at a 61.08% annual growth rate that is well above the industry average of 18.10%.

Forte Biosciences Inc (NASDAQ:FBRX)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 10.94% of Forte Biosciences Inc shares, and 54.05% of them are in the hands of institutional investors. The stock currently has a share float of 60.69%. Forte Biosciences Inc stock is held by 27.0 institutions, with TYBOURNE CAPITAL MANAGEMENT (HK) LTD being the largest institutional investor. By 2024-06-30, it held 7.8653% of the shares, which is about 3.62 million shares worth $1.95 million.

PERCEPTIVE ADVISORS LLC, with 7.0858% or 3.27 million shares worth $1.75 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Alger Health Sciences Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Jul 31, 2024. The former held 47.71 shares worth $0.83 million, making up 3.26% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 19.5 shares worth around $0.34 million, which represents about 1.33% of the total shares outstanding.